Filed in archive
Cancer
, FDA Approvals
, Treatment
by Gloria Gamat on September 16, 2008
The US FDA has recently approved additional uses for Merck's controversial HPV vaccine Gardasil: prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.
Read more from FDA News.
"There is now strong evidence showing that this vaccine can help prevent vulvar and vaginal cancers due to the same viruses for which it also helps protect against cervical cancer," said Jesse L. Goodman, M.D., M.P.H., director of the FDA's Center for Biologics Evaluation and Research. "While vulvar and vaginal cancers are rare, the opportunity to help prevent them is potentially an important additional benefit from immunization against HPV."
The FDA originally approved Gardasil in 2006 for girls and women ages 9 to 26 for the prevention of cervical cancer caused by HPV types 16 and 18, precancerous genital lesions caused by HPV types 6, 11, 16, and 18 and genital warts caused by HPV types 6 and 11.
Read more from FDA News.
Permalink: Merck's Gardasil, Approved For New Uses
Tags:
HPV
cervical
cancer
vaginal
cancer
vulvar
cancer
Gardasil
cervical
cancer
vaccine.
health
contact+le
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/133959
Mr Wong
Vote for Merck's Gardasil, Approved For New Uses:
|
Rating: 6.50 out of 4 vote(s) cast.
|
Response from:
Trusted.MD Network
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |










